Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse Model
© 2017 by the American Diabetes Association..
Both mammals and adult humans possess classic brown adipocytes and beige adipocytes, and the amount and activity of these adipocytes are considered key factors in combating obesity and its associated metabolic diseases. Uncoupling protein 1 (Ucp1) is the functional marker of both brown and beige adipocytes. To facilitate a reliable, easy, and sensitive measurement of Ucp1 expression both in vivo and in vitro, we generated a Ucp1-2A-luciferase knock-in mouse by deleting the stop codon for the mouse Ucp1 gene and replacing it with a 2A peptide. This peptide was followed by the luciferase coding sequence to recapitulate the expression of the Ucp1 gene at the transcriptional and translational levels. With this mouse, we discovered a cold-sensitive brown/beige adipose depot underneath the skin of the ears, which we named uBAT. Because of the sensitivity and high dynamic range of luciferase activity, the Ucp1-2A-luciferase mouse is useful for both in vitro quantitative determination and in vivo visualization of nonshivering thermogenesis. With the use of this model, we identified and characterized axitinib, an oral small-molecule tyrosine kinase inhibitor, as an effective browning agent.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Diabetes - 66(2017), 2 vom: 01. Feb., Seite 407-417 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mao, Liufeng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Axitinib |
|---|
| Anmerkungen: |
Date Completed 05.06.2017 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2337/db16-0343 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM268203873 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM268203873 | ||
| 003 | DE-627 | ||
| 005 | 20231224222223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2337/db16-0343 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0894.xml |
| 035 | |a (DE-627)NLM268203873 | ||
| 035 | |a (NLM)28108609 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mao, Liufeng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse Model |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.06.2017 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2017 by the American Diabetes Association. | ||
| 520 | |a Both mammals and adult humans possess classic brown adipocytes and beige adipocytes, and the amount and activity of these adipocytes are considered key factors in combating obesity and its associated metabolic diseases. Uncoupling protein 1 (Ucp1) is the functional marker of both brown and beige adipocytes. To facilitate a reliable, easy, and sensitive measurement of Ucp1 expression both in vivo and in vitro, we generated a Ucp1-2A-luciferase knock-in mouse by deleting the stop codon for the mouse Ucp1 gene and replacing it with a 2A peptide. This peptide was followed by the luciferase coding sequence to recapitulate the expression of the Ucp1 gene at the transcriptional and translational levels. With this mouse, we discovered a cold-sensitive brown/beige adipose depot underneath the skin of the ears, which we named uBAT. Because of the sensitivity and high dynamic range of luciferase activity, the Ucp1-2A-luciferase mouse is useful for both in vitro quantitative determination and in vivo visualization of nonshivering thermogenesis. With the use of this model, we identified and characterized axitinib, an oral small-molecule tyrosine kinase inhibitor, as an effective browning agent | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Imidazoles |2 NLM | |
| 650 | 7 | |a Indazoles |2 NLM | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a Ucp1 protein, mouse |2 NLM | |
| 650 | 7 | |a Uncoupling Protein 1 |2 NLM | |
| 650 | 7 | |a Axitinib |2 NLM | |
| 650 | 7 | |a C9LVQ0YUXG |2 NLM | |
| 650 | 7 | |a Luciferases |2 NLM | |
| 650 | 7 | |a EC 1.13.12.- |2 NLM | |
| 700 | 1 | |a Nie, Baoming |e verfasserin |4 aut | |
| 700 | 1 | |a Nie, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Hui, Xiaoyan |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Xuefei |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Xiaoliang |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Xiaofeng |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Ran |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Kuai |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Peng |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Aimin |e verfasserin |4 aut | |
| 700 | 1 | |a Fei, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Weiping |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Pentao |e verfasserin |4 aut | |
| 700 | 1 | |a Madsen, Lise |e verfasserin |4 aut | |
| 700 | 1 | |a Kristiansen, Karsten |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Zhiguang |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Sheng |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Donghai |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes |d 1952 |g 66(2017), 2 vom: 01. Feb., Seite 407-417 |w (DE-627)NLM000060011 |x 1939-327X |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2017 |g number:2 |g day:01 |g month:02 |g pages:407-417 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2337/db16-0343 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2017 |e 2 |b 01 |c 02 |h 407-417 | ||